Laseroptek Co., Ltd.
Financials
Valuation Metrics
Laseroptek Co., Ltd.'s Market Cap is ₩431B. At end of 2025 it was ₩769B. Ranked #1809 of 2,405 in KR market (top 75%), #1110 of 1,627 on KOSDAQ (top 68%), #74 of 94 in Health Care Equipment & Services (top 79%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 43.05B KRW | KR#1,809/2,405 Sec#74/94 |
| Revenue | 31.68B KRW | KR#2,006/2,405 Sec#65/94 |
| Net Income | -6.94B KRW | KR—/2,405 Sec—/94 |
| Total Assets | 46.33B KRW | KR#2,227/2,405 Sec#76/94 |
| Net Assets | 30.06B KRW | KR#2,166/2,405 Sec#78/94 |
| Employees | 79 | KR#1,812/2,405 Sec#71/94 |
| Value | ||
| P/B | 1.43x | KR#1,791/2,405 Sec#58/94 |
| P/S | 1.36x | KR#1,639/2,405 Sec#41/94 |
| FCF Yield | -16.49% | KR—/2,405 Sec—/94 |
| Profitability | ||
| ROE | -23.10% | KR#2,111/2,405 Sec#76/94 |
| ROA | -14.98% | KR#2,178/2,405 Sec#77/94 |
| Op. Margin | -32.86% | KR#2,174/2,405 Sec#74/94 |
| Revenue Growth | 33.82% | KR#339/2,405 Sec#16/94 |
| Financial Health | ||
| Debt Ratio | 54.16% | KR#1,013/2,405 Sec#59/94 |
| Total Debt | 7.83B KRW | KR#1,685/2,405 Sec#52/94 |
| FCF | -7.10B KRW | KR#1,588/2,405 Sec#54/94 |
| Cash | 9.82B KRW | KR#1,701/2,405 Sec#57/94 |
| Current Ratio | 2.64x | KR#641/2,405 Sec#38/94 |
| Performance | ||
| 1Y Return | -51.13% | KR#1,972/2,405 Sec#74/94 |
| 1M Return | -10.08% | KR#1,173/2,405 Sec#45/94 |
| From 52W High | -62.34% | KR#1,766/2,405 Sec#60/94 |
| 1Y MDD | -66.29% | KR#1,781/2,405 Sec#63/94 |
| Trading | ||
| Volume | 14,952 shares | KR#1,656/2,405 Sec#63/94 |
| Trading Value | 43.4M KRW | KR#1,796/2,405 Sec#72/94 |
| Foreign Own. | 1.84% | KR#1,681/2,405 Sec#61/94 |
| Per Share | ||
| EPS | -468 KRW | KR—/2,405 Sec—/94 |
| BPS | 2,025 KRW | KR#2,069/2,405 Sec#68/94 |
Company Info
LASEROPTEK, established in 2000, specializes in developing and manufacturing medical devices based on laser original technology, and was listed on KOSDAQ in 2024. Initially, it developed laser products for semiconductor and automobile manufacturing processes, but later expanded into skin aesthetics and disease treatment fields following the growth of the beauty device market. The company entered the domestic laser beauty device market in 2005 with LOTUS and HELIOS, achieving overseas expansion in 2009 with US FDA and Europe CE certifications. LASEROPTEK is headquartered in Seongnam-si, Gyeonggi-do.